| 产品编号 |
产品名称 |
序列 |
别称 |
CAS Number |
分子式 |
分子量 |
疾病类 |
包装 |
| CS19550 |
SARS-CoV-2 Spike GlycoProtein, 747-763
|
序列
|
|
|
C83H130N20O28S2 |
1920.28 |
|
|
| Thr-Glu-Cys-Ser-Asn-Leu-Leu-Leu-Gln-Tyr-Gly-Ser-Phe-Cys-Thr-Gln-Leu |
| CS19551 |
SARS-CoV-2 Spike GlycoProtein, 647-664
|
序列
|
|
|
C79H122N22O29S2 |
1908.18 |
|
|
| Ala-Gly-Cys-Leu-Ile-Gly-Ala-Glu-His-Val-Asn-Asn-Ser-Tyr-Glu-Cys-Asp-Ile |
| CS19553 |
SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335
|
序列
|
|
|
C88H146N26O26 |
1984.38 |
|
|
| H-Arg-Val-Gln-Pro-Thr-Glu-Ser-Ile-Val-Arg-Phe-Pro-Asn-Ile-Thr-Asn-Leu-OH |
| CS19555 |
SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347
|
序列
|
|
|
C64H90N16O17S |
1387.62 |
|
|
| H-Cys-Pro-Phe-Gly-Glu-Val-Phe-Asn-Ala-Thr-Arg-Phe-OH |
| CS19557 |
SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357
|
序列
|
|
|
C56H87N19O14 |
1250.46 |
|
|
| H-Ala-Ser-Val-Tyr-Ala-Trp-Asn-Arg-Lys-Arg-OH |
| CS19559 |
SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365
|
序列
|
|
|
C73H114N24O21S |
1695.97 |
|
|
| H-Ala-Trp-Asn-Arg-Lys-Arg-Ile-Ser-Asn-Cys-Val-Ala-Asp-Tyr-OH |
| CS19561 |
SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394
|
序列
|
|
|
C117H176N28O37S2 |
2631.07 |
|
|
| H-Ser-Ala-Ser-Phe-Ser-Thr-Phe-Lys-Cys-Tyr-Gly-Val-Ser-Pro-Thr-Lys-Leu-Asn-Asp-Leu-Cys-Phe-Thr-Asn-OH |
| CS19563 |
SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430
|
序列
|
|
|
C183H277N47O58 |
4063.67 |
|
|
| H-Val-Tyr-Ala-Asp-Ser-Phe-Val-Ile-Arg-Gly-Asp-Glu-Val-Arg-Gln-Ile-Ala-Pro-Gly-Gln-Thr-Gly-Lys-Ile-Ala-Asp-Tyr-Asn-Tyr-Lys-Leu-Pro-Asp-Asp-Phe-Thr-OH |
| CS19565 |
SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520
|
序列
|
|
|
C44H68N10O12 |
929.13 |
|
|
| H-Leu-Ser-Phe-Glu-Leu-Leu-His-Ala-OH |
| CS19567 |
SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541
|
序列
|
|
|
C90H154N26O26S2 |
2080.59 |
|
|
| H-Thr-Val-Cys-Gly-Pro-Lys-Lys-Ser-Thr-Asn-Leu-Val-Lys-Asn-Lys-Cys-Val-Asn-Phe-OH |
| CS19569 |
SARS - CoV - 2 Spike RBM (receptor binding motif), 438 - 458
|
序列
|
|
|
C113H173N33O33 |
2521.93 |
|
|
| H-Ser-Asn-Asn-Leu-Asp-Ser-Lys-Val-Gly-Gly-Asn-Tyr-Asn-Tyr-Leu-Tyr-Arg-Leu-Phe-Arg-Lys-OH |
| CS19570 |
SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473
|
序列
|
|
|
C142H217N37O39 |
3066.63 |
|
|
| H-Asn-Tyr-Leu-Tyr-Arg-Leu-Phe-Arg-Lys-Ser-Asn-Leu-Lys-Pro-Phe-Glu-Arg-Asp-Ile-Ser-Thr-Glu-Ile-Tyr-OH |
| CS19572 |
SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496
|
序列
|
|
|
C85H116N20O26S2 |
1898.18 |
|
|
| H-Cys-Asn-Gly-Val-Glu-Gly-Phe-Asn-Cys-Tyr-Phe-Pro-Leu-Gln-Ser-Tyr-Gly-OH |
| CS19574 |
SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509
|
序列
|
|
|
C51H75N15O16 |
1154.3 |
|
|
| H-Thr-Asn-Gly-Val-Gly-Tyr-Gln-Pro-Tyr-Arg-OH |
| CS19577 |
DX 600, ACE2 Inhibitor
|
序列
|
|
|
C141H187N35O40S2 |
3076.49 |
|
|
| Ac-Gly-Asp-Tyr-Ser-His-Cys-Ser-Pro-Leu-Arg-Tyr-Tyr-Pro-Trp-Trp-Lys-Cys-Thr-Tyr-Pro-Asp-Pro-Glu-Gly-Gly-Gly-NH2 |
| CS19771 |
Bremelanotide
|
序列
|
|
189691-06-3 |
C50H68N14O10 |
1025.163 |
|
|
| Ac-Nle-cyclo[Asp-His-D-2Nal-Arg-Trp-Lys]-NH2 |
| CS19921 |
HK-HELP WT-1
|
序列
|
|
|
|
|
|
|
| Arg-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu-Gly-Gly-Gly-Gly-Gly-Lys-Arg-Tyr-Phe-Lys-Leu-Ser-His-Leu-Gln-Met-His-Ser-Arg-Lys-His-Gly-Gly-Gly-Gly-Gly-Cys-Tyr-Thr-Trp-Asn-Gln-Met-Asn-Leu |
| CS19922 |
HK-HELP survivin
|
序列
|
|
|
|
|
|
|
| Glu-His-Lys-Lys-His-Ser-Ser-Gly-Cys-Ala-Phe-Leu-Ser-Val-Lys-Lys-Gln-Phe-Glu-Gly-Gly-Gly-Gly-Gly-Gly-Phe-Leu-Lys-Leu-Asp-Arg-Glu-Arg-Ala-Lys-Asn-Lys-Gly-Gly-Gly |
| CS2163 |
TETA0, Octreotide
|
序列
|
|
|
|
|
|
|
| TETA-(D-Phe)-Cys-Phe-(D-Trp)-Lys-Thr-Cys-Thr-Ol (Disulfide bond Cys2/Cys7) |
| CS2164 |
9-Tyrosine
|
序列
|
|
|
C81H83N9O19 |
1486.5 |
|
|
| Tyr-Tyr-Tyr-Tyr-Tyr-Tyr-Tyr-Tyr-Tyr |
沪公网安备 31011502005552号
沪ICP备13005633号-1